Amarin Corp Plc (AMRN)

[rosemountbomber]

Part of the problem is the ignorance and stupidity of doctors (what do you call a med student who graduates at the bottom of his class? - Doctor) and the other is that Amarin lost the patent battle in the DuDisaster so shortly after R-I label expansion that they curtailed their advertising shortly thereafter.

If Brave is successful, the company could try to leverage that in the EU, but you are correct that in the U.S., generics would grab a bulk of scripts.

As far as Ozempic, another example of moronic doctors. The lawsuits are coming out of the woodwork now about those serious side effects. Of course doctors get played by the advertising as much as by their patients.